SCHEMBL3870280

SCHEMBL3870280

COc1c(O)cc2c(=O)oc3c(O)c(OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc4c(=O)oc1c2c34

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 1/20 0.56
MGAM O43451 1/20 0.55
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
MAPT P10636 3/20 0.55
HPGD P15428 3/20 0.55
ALDH1A1 P00352 2/20 0.55
KDM4E B2RXH2 1/20 0.55
APEX1 P27695 1/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
CA12 O43570 2/20 0.55
CA1 P00915 2/20 0.55
CA7 P43166 2/20 0.55
CA9 Q16790 2/20 0.55
CA13 Q8N1Q1 2/20 0.55
SOST Q9BQB4 1/20 0.53
CYP3A4 P08684 2/20 0.49
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30658623 0.90 RELA (0.60) RELAMGAMMEN1KMT2AMAPT
SCHEMBL29585250 0.90 SOST (0.53) MGAMMEN1KMT2AMAPTHPGD
SCHEMBL1699331 0.89 HSD17B10 (0.52) MGAMMEN1KMT2AMAPTHPGD
SCHEMBL29365350 0.87 CA12 (0.55) RELAMGAMMEN1KMT2AMAPT
SCHEMBL1279584 0.87 SOST (0.60) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL1444961 0.87 SOST (0.60) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL1279902 0.86 SOST (0.59) MGAMMEN1KMT2AMAPTHPGD
SCHEMBL31290780 0.84 XDH (0.53) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30637413 0.82 RELA (0.58) RELAMGAMMEN1KMT2AMAPT
SCHEMBL31621907 0.80 KMT2A (0.50) MGAMMEN1KMT2AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143318-A1 DEGRANULATION INHIBITOR TROPICAL TECHNOLOGY CENTER LTD. (JP) 2009-06-04 US disclosed
EP-2025680-A1 DEGRANULATION INHIBITOR Tropical Technology Center Ltd. (JP) 2009-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143318-A1 DEGRANULATION INHIBITOR CMA1, MRGPRX1, MRGPRX2 RELA 337/4885MGAM 157/4885MEN1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.